Bristol-Myers drug raises blood sugar risk: study
Posted on: Thursday, 2 March 2006, 19:11 CST
BOSTON (Reuters) - The Bristol Myers Squibb Co. antibiotic Tequin can have "life threatening" side effects including low blood sugar, according to a Canadian study on Wednesday.
Elderly people who took Tequin were 17 times more likely to develop high blood sugar than if they took another antibiotic, and were four times more likely to be hospitalized for low blood sugar, the study found.
The study was to be published in The New England Journal of Medicine on March 30 but it was released early because of its important public health implications, the journal said.
Source: REUTERS
Related Articles
- The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
- Study: Sugar Ups Pancreatic Cancer Risk
- US senator demands FDA answers on blood study
- Senator Demands FDA Answers on Blood Study
- Officials: Substitute Blood Study Unethical
- Northfield defends controversial US blood study
- US senator questions FDA-approved blood study
- Senator Questions FDA-approved Blood Study
- Chicago Hospital Joins Fake Blood Study
- Robot Blood Studied in Space
Rating: 2.4 / 5 (12 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds